Anxiolytic & Hypnotic Agents – Benzodiazepines and Non-Benzodiazepines

Learning Objective

  • Describe mechanism of action, common adverse effects and clinical considerations of

    • Benzodiazepines (BZDs)

    • Non-benzodiazepine agents (barbiturates, “Z-drugs”, melatonin)

  • Context: management of anxiety, insomnia, muscle spasm, seizures, peri-procedural amnesia

γ-Aminobutyric Acid (GABA) Receptor Biology (Recap)

  • Two major GABA receptor families

    • GABA$_A$ (ligand-gated Cl−^- channel) ⇨ central to all drugs discussed

    • GABA$_B$ (GPCR, less relevant here)

  • GABA$_A$ receptor complex contains multiple modulatory sites

    • Benzodiazepine 1 (BZ1) site → anxiolysis & sedation

    • Benzodiazepine 2 (BZ2) site → muscle relaxation, learning/memory changes

    • Other subunits modulate seizure threshold

  • Activation sequence

    1. GABA binds core receptor

    2. Channel opens ➝ Cl−^- influx

    3. Membrane hyperpolarises ↑\uparrow negative charge

    4. Neuronal excitability ↓

Benzodiazepines (BZDs)

Mechanism of Action

  • Positive allosteric modulators at GABA$_A$ BZ site

  • Potentiate—not replace—GABA ➝ ceiling effect for CNS depression

  • Net effect: enhanced Cl−^- influx, hyperpolarisation, reduced firing

Functional Selectivity

  • BZ1-predominant drugs (e.g., some hypnotics) → stronger sedation

  • BZ2-predominant drugs (e.g., midazolam) → pronounced anterograde amnesia, muscle relaxation

Pharmacological Effects

  • Desired

    • Anxiolysis

    • Sedation / hypnosis

    • Anticonvulsant activity

    • Muscle relaxation

    • Anterograde amnesia (procedures, fracture reduction)

  • Undesired / paradoxical

    • Diplopia, blurred vision, slurred speech

    • Paradoxical rage, paradoxical insomnia

    • Depression, dizziness

    • Cognitive impairment (especially with prolonged high-dose use)

Safety & Toxicology

  • Safest major CNS depressant class

    • Lethal overdose rare when taken alone

    • Deaths usually involve ethanol/other depressants

  • Specific antidote: Flumazenil (competitive antagonist)

  • Physical & psychological dependence

    • Withdrawal may begin after ≈2 weeks continuous use

    • Tolerance develops ➝ escalating doses required

Drug-Specific Clinical Pearls

  • Midazolam: strong BZ2 action ⇨ procedural amnesia

  • Diazepam & Clonazepam (long t1/2_{1/2}) ⇨ chronic muscle spasm, anti-seizure, but high addiction potential

  • Temazepam: t1/2_{1/2} ≈ 8 h8\,\text{h} ⇨ ideal sleep aid (short-term)

  • Long t1/2_{1/2} agents better for daytime anxiolysis but carry greater residual sedation & accumulation

Broad Adverse-Effect Summary

  • Sedation, psychomotor slowing, ataxia

  • Amnesia (helpful peri-procedure)

  • Respiratory depression (rare unless combined with other depressants)

  • Visual disturbances

  • Dependence, withdrawal, tolerance

Non-Benzodiazepine Agents

1. Barbiturates

  • MOA: bind distinct site on GABA$_A$; directly increase channel open time → stronger CNS depression

  • Narrow therapeutic index → potentially fatal overdose (respiratory depression)

  • Adverse effects: profound sedation, mental dulling, memory impairment, mood lability, tolerance, dependence, death

  • Current niche uses: palliative sedation (paediatric & adult), refractory epilepsy

2. “Z-Drugs”
a) Zolpidem

  • Binds BZ1 site as agonist (selective)

  • Minimal anticonvulsant / muscle relaxant action

  • Adverse: tolerance, dependence, withdrawal (drowsiness, dizziness, GI cramps/diarrhoea)

  • Clinical rules

    • Limit to ≤4 weeks; high misuse potential

    • High dose ➝ amnesia

    • Formulations

    • Immediate release → sleep induction

    • Controlled release → sleep maintenance

b) Zopiclone

  • Likely binds BZD receptor at alternate locus; still enhances GABA

  • Adverse: bitter/metallic taste, drowsiness, impaired alertness & coordination, confusion, mood change

  • Dependence risk; avoid alcohol

  • Elderly ⇨ higher incidence of side-effects

3. Melatonin

  • First-line for primary insomnia / circadian rhythm disruption

  • MOA: agonist at MT1 / MT2 GPCRs → inhibits adenylate cyclase, re-synchronises circadian clock

  • Adverse: headaches, GI upset, arthralgia/back pain, nasal irritation/nosebleed

  • Clinical highlights

    • Safe in overdose; no dependence, no rebound insomnia

    • Alcohol avoidance recommended (blunts efficacy)

Comparative Table (Key Points)

  • Benzodiazepines

    • Ceiling effect; low lethality; flumazenil antidote

    • Dependence common

    • Useful for anxiety, insomnia, seizures, muscle spasm, procedural amnesia

  • Barbiturates

    • High lethality; no easy antidote; historical use

    • Reserved for palliative care or refractory seizures

  • Z-drugs (Zolpidem, Zopiclone)

    • Selective hypnotics; short-term only (≤4 weeks)

    • Dependence & tolerance similar to BZDs

  • Melatonin

    • Physiologic hormone replacement; safest profile; first-line sleep aid

Practical / Ethical / Real-World Considerations

  • Long-term BZD or Z-drug use → cognitive decline, accident risk (falls, MVA)

  • Prescribers must weigh short-term benefit vs long-term harm (dependence, tolerance, depression)

  • Patient education vital:

    • Limit duration

    • Avoid alcohol & other depressants

    • Recognise withdrawal signs

  • Relevance to nursing & shift-work: Temazepam frequently requested; alternative (melatonin, sleep hygiene) preferred

Conceptual Connections

  • Builds on prior lectures covering synaptic transmission & inhibitory neurotransmission (GABA)

  • Demonstrates pharmacodynamic selectivity within a single receptor class (subunit-specific effects)

  • Illustrates pharmacokinetic tailoring (half-life, formulation) to therapeutic goal (sleep onset vs maintenance, daytime anxiolysis)

Key Numbers & Equations

  • Temazepam t1/2_{1/2} ≈ 8 h8\,\text{h} (ideal overnight but minimal morning hangover)

  • Withdrawal onset in chronic BZD users: ≈ 14 days14\,\text{days} continuous dosing

  • Cl−^- influx → membrane potential Vm ↓V_m\, \downarrow (hyperpolarisation)

Study Checklist

  • Explain difference between BZ1 vs BZ2 receptor effects

  • List at least five common BZD adverse effects & their mechanisms

  • Interpret why BZD overdose alone is rarely fatal but becomes lethal with ethanol

  • Match drug to scenario:

    • Midazolam → peri-op amnesia

    • Diazepam → acute muscle spasm

    • Temazepam → transient insomnia

    • Melatonin → jet-lag / shift-work sleep disorder

  • Know flumazenil dosing considerations & precautions (seizure risk in mixed overdoses)

Learning Objective

  • Understand how Benzodiazepines (BZDs) and non-benzodiazepine drugs (barbiturates, “Z-drugs”, melatonin) work, their side effects, and clinical uses.

  • Context: Used for anxiety, insomnia, muscle spasms, seizures, and pre-procedure memory loss.

γ-Aminobutyric Acid (GABA) Receptor Biology (Recap)

  • Two main GABA receptors:

    • GABAA_A: A chloride ion (Cl−^-) channel, crucial for these drugs.

    • GABAB_B: Less relevant here.

  • GABAA_A receptor has other sites:

    • Benzodiazepine 1 (BZ1) site: for anxiety relief & sedation.

    • Benzodiazepine 2 (BZ2) site: for muscle relaxation, and affects memory/learning.

    • Other parts influence seizure activity.

  • How it works:

    1. GABA attaches to the receptor.

    2. Channel opens, Cl−^- enters the cell.

    3. Cell becomes more negative (hyperpolarised).

    4. Neuron activity decreases.

Benzodiazepines (BZDs)
Mechanism of Action

  • They enhance the effect of GABA at the GABAA_A BZ site.

  • They boost GABA's action, but don't replace it, so there's a limit to how much CNS depression they cause.

  • Result: More Cl−^- influx, making neurons less active.

Functional Selectivity

  • BZ1-targeting drugs (like some sleep aids) cause more sedation.

  • BZ2-targeting drugs (like midazolam) cause memory loss and muscle relaxation.

Pharmacological Effects

  • Desired: Reduce anxiety, cause sleep, stop seizures, relax muscles, cause memory loss (useful for procedures).

  • Undesired/Paradoxical: Double vision, blurred vision, slurred speech, unexpected agitation, depression, dizziness, memory problems (long-term high dose).

Safety & Toxicology

  • Generally safe if taken alone; lethal overdose is rare.

  • Fatalities usually happen when combined with alcohol or other depressants.

  • Antidote: Flumazenil (reverses BZD effects).

  • Can cause dependence (physical & psychological).

  • Withdrawal symptoms can appear after about 2 weeks of daily use.

  • Tolerance develops, meaning higher doses are needed over time.

Drug-Specific Clinical Pearls

  • Midazolam: Good for procedural memory loss due to strong BZ2 effect.

  • Diazepam & Clonazepam (long-acting): Used for chronic muscle spasms and seizures, but high addiction risk.

  • Temazepam (half-life ≈ 8 h8\,\text{h}): Good for short-term sleep aid.

  • Long-acting BZDs are better for daytime anxiety but cause more daytime drowsiness and build up in the body.

Broad Adverse-Effect Summary

  • Drowsiness, slow movements, poor coordination.

  • Memory loss.

  • Breathing problems (rare, unless combined with other depressants).

  • Vision issues.

  • Dependence, withdrawal, tolerance.

Non-Benzodiazepine Agents
1. Barbiturates

  • MOA: Bind a different GABAA_A site; directly increase how long the channel stays open, causing strong CNS depression.

  • Narrow safety margin: Overdose can be fatal due to breathing stopping.

  • Adverse Effects: Deep sedation, reduced mental function, memory issues, mood swings, tolerance, dependence, death.

  • Current Uses: Palliative sedation (for comfort in severe illness), severe epilepsy that doesn't respond to other drugs.

2. “Z-Drugs”

a) Zolpidem

  • Acts like a BZD, but mostly at the BZ1 site (selective).

  • Little effect on seizures or muscles.

  • Adverse: Tolerance, dependence, withdrawal (drowsiness, dizziness, GI issues).

  • Clinical Rules: Use for ≤4 weeks; high potential for misuse.

    • High doses can cause memory loss.

    • Immediate release: for falling asleep.

    • Controlled release: for staying asleep.

b) Zopiclone

  • Also enhances GABA, likely at a different BZD receptor site.

  • Adverse: Metallic taste, drowsiness, impaired alertness/coordination, confusion, mood changes.

  • Risk of dependence; avoid alcohol.

  • Elderly are more prone to side effects.

3. Melatonin

  • First choice for basic insomnia or sleep rhythm issues.

  • MOA: Mimics natural melatonin by acting on MT1/MT2 receptors, helping reset the body's clock.

  • Adverse: Headaches, upset stomach, joint/back pain, nasal irritation.

  • Clinical Highlights: Safe in overdose; no dependence or rebound insomnia.

    • Avoid alcohol (reduces its effectiveness).

Comparative Table (Key Points)

  • Benzodiazepines: Limited CNS depression (ceiling effect); low death risk alone; reversed by flumazenil. Common dependence. Good for anxiety, insomnia, seizures, muscle spasms, procedural amnesia.

  • Barbiturates: High death risk; no easy antidote; old drugs. Used for comfort care or severe seizures.

  • Z-drugs (Zolpidem, Zopiclone): Selective for sleep; only for short-term use (≤4 weeks). Dependence/tolerance similar to BZDs.

  • Melatonin: Natural; safest profile; first-line sleep aid.

Practical / Ethical / Real-World Considerations

  • Long-term BZD or Z-drug use: Can cause cognitive decline, higher risk of accidents (falls, car crashes).

  • Doctors must weigh short-term benefits against long-term harms (dependence, tolerance, depression).

  • Patient education is key: Limit use, avoid alcohol/other depressants, recognize withdrawal signs.

  • For nurses/shift workers, Temazepam is often requested, but melatonin or sleep hygiene are better alternatives.

Key Numbers & Equations

  • Temazepam half-life: ≈ 8 h8\,\text{h}.

  • BZD withdrawal onset: ≈ 14 days14\,\text{days} of continuous use.

  • Cl−^- influx makes membrane potential (VmV_m) more negative (hyperpolarisation).

Study Checklist

  • Explain BZ1 vs BZ2 receptor effects.

  • List five common BZD side effects and why they happen.

  • Understand why BZD overdose alone is rarely fatal but dangerous with alcohol.

  • Match drugs to uses:

    • Midazolam: pre-surgery memory loss.

    • Diazepam: acute muscle spasms.

    • Temazepam: temporary insomnia.

    • Melatonin: jet lag/shift work sleep issues.

  • Know how to dose Flumazenil and its risks (e.g., seizure risk in mixed overdoses).